The Saudi Arabia diabetic foot ulcer treatment market size surpassed USD 38.83 million in 2025 and is predicted to reach around USD 77.46 million by 2035, registering a CAGR of 7.15% from 2026 to 2035. The rising prevalence of diabetes and demand for advanced wound care to prevent amputation are boosting the market.

Saudi Arabia Diabetic Foot Ulcer Treatment Market Statical Scope

Diabetic foot ulcers represent a significant complication faced by individuals with diabetes, as their wound healing capability is severely diminished. This condition typically results in the formation of wounds, predominantly on the feet of patients, which can undergo rapid decomposition, consequently leading to the proliferation of infectious microorganisms in the affected area.

The escalating prevalence of diabetes in Saudi Arabia has markedly heightened the risk of developing diabetic foot ulcers. This increasing diabetic burden directly correlates with a rise in diabetes-related complications, including foot ulcers. Furthermore, the growth of the market for diabetic foot ulcer treatments in Saudi Arabia can be attributed to the substantial investments being made in healthcare infrastructure and advanced medical technologies.

Saudi Arabia Diabetic Foot Ulcer Treatment Market Share, By Treatment, 2025, (%)

• Wound care dressings - Wound care dressings are the first line of treatment for infection control and wound healing management, with a 34% share, establishing wound care dressings as the dominating treatment segment in the Saudi Arabia diabetic foot ulcer treatment market.
• Biologics - Advanced healing solutions with higher costs, with a 18% share, driven by advancements in regenerative medicines .
• Antibiotic medications - Essential for infection prevention and treatment, with a 22% share driven by infections of bacteria such as MRSA (methicillin-resistant S. aureus) and other gram-negative bacteria.
• Therapy devices - Use in advanced wound healing technologies, with a 16% share, driven by demand for new diabetic foot ulcer therapies and larger-scale implementation of new wound care devices.

Saudi Arabia Diabetic Foot Ulcer Treatment Market Share, By Ulcer Type, 2025, (%)

• Neuropathic ulcers- Rising prevalence among diabetic patients due to nerve damage, with a 53% share, establishes this as the dominating ulcer type segment.
• Neuro-ischemic ulcers - A combination of nerve and blood flow issues, with a 26% share, growing significantly due to the increasing prevalence of peripheral artery disease.
• Ischemic ulcers - Ischemic ulcers are caused by poor blood circulation and hold 21% share.

Saudi Arabia Diabetic Foot Ulcer Treatment Market Share, By End Use, 2025, (%)

• Homecare - Growing preference for cost-effective and convenient at-home treatment, with a 51% share, contributes to homecare as the dominating end-use segment.
• Hospitals - Used for severe and critical cases, with a 33% share, driven by surgical interventions and specialized care for severe infections.
• Ambulatory surgery centres - These centres are used for specialized procedures, with a 16%

Top Companies in the Saudi Arabia Diabetic Foot Ulcer Treatment Market

• ConvaTec, Group Plc
• 3M Health Care
• Coloplast Corp.
• Smith & Nephew Plc
• B Braun Melsungen AG
• Medline Industries, LP.
• Molnlycke Health Care AB
• Medtronic Plc

Segments Covered in the Report

By Treatment

• Wound Care Dressings
  • Alginate Dressings
  • Hydrofiber Dressings
  • Foam Dressings
  • Film Dressing
  • Hydrocolloid Dressings
  • Surgical Dressings
  • Hydrogel Dressings
• Biologics
  • Growth Factors
  • Skin Grafts
• Therapy Devices
  • Negative Pressure Wound Therapy
  • Ultrasound Therapy
• Antibiotic Medications
• Others

By Ulcer Type

• Neuropathic Ulcers
• Ischemic Ulcers
• Neuro-ischemic Ulcers

By End-use

• Hospitals
• Ambulatory surgery centers
• Homecare